More on ALKS
Data
Financials
News
|
ALKERMES (NQ:ALKS)
Delayed: 29.38
-0.53 (1.77%)
|
Trade Now! |
|
||||
|---|---|---|---|---|---|---|
| Previous Close | $29.91 | 52 Week High | $34.30 | |||
| Open | $29.82 | 52 Week Low | $15.46 | |||
| Day High | $30.04 | P/E | N/A | |||
| Day Low | $29.10 | EPS | $0.00 | |||
| Volume | 442,290 | |||||
- Form 4 Alkermes plc. For: Jun 12 Filed by: FRATES JAMES M
- Form 4 Alkermes plc. For: Jun 03 Filed by: BREYER ROBERT A
- Form 4 Alkermes plc. For: Jun 03 Filed by: Ehrich Elliot
- Form 4 Alkermes plc. For: May 30 Filed by: Pugh Gordon G
- Alkermes (ALKS) Issues Positive Update for ALKS 5461 Phase 2
- Alkermes Presents Positive Results from Phase 2 Clinical Study of ALKS 5461 in Major Depressive Disorder at 53rd Annual NCDEU Meeting
- Form 4 Alkermes plc. For: May 26 Filed by: Peterson Rebecca
- Form 4 Alkermes plc. For: May 28 Filed by: Cooke Shane
- Form 4 Alkermes plc. For: May 28 Filed by: POPS RICHARD F
- Form 4 Alkermes plc. For: May 28 Filed by: Stejbach Mark
Entities mentioned with ALKS
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Citi | View Related Stories »
- Bank of America | View Related Stories »
- UBS | View Related Stories »
- Morgan Stanley | View Related Stories »
- JPMorgan | View Related Stories »
- Trading Radar | View Related Stories »
- Show More...
